NCT06262178 Parenting STAIR: Adapting a Trauma-Focused Parenting Intervention for Military-Connected Mothers and Their Children
| NCT ID | NCT06262178 |
| Status | Recruiting |
| Phase | — |
| Sponsor | New York University |
| Condition | PTSD |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-07-21 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2025-07-21 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to assess Parenting STAIR Modular (PSTAIR-M), a promising and innovative intervention for military-connected mothers (MCM) who have experienced trauma and their young children (ages 2-10). PSTAIR-M aims to help mothers manage the strong feelings that sometimes happen after experiencing something scary or stressful, as well as to better connect with their children and manage their behavior effectively. The main questions the study aims to answer are: 1) Does PSTAIR-M reduce maternal PTSD and/or depression symptoms?, and 2) Does PSTAIR-M improve parental functioning? Researchers will compare PSTAIR-M to treatment as usual (TAU) - other EBTs offered at participating study sites - to determine if PSTAIR-M is more effective in improving mental health and parenting. Participants will: 1) attend 12-16 weekly, 1-hour online treatment sessions with their assigned clinicians, 2) complete three 1-hour online assessments administered by research staff, 3) engage with their child in three 15-30-minute online, observed play sessions, and 4) have assessments audio and video recorded.
Eligibility Criteria
Inclusion Criteria: 1. Military-connected mother, defined as a mother who is either a female service member or veteran or female spouse of a service member or veteran; 2. Has a child aged 2-10; 3. Legal guardian of index child with legal and physical custody; 4. Lifetime trauma exposure (Life Events Checklist (LEC-5); Adverse Childhood Experiences Questionnaire (ACE-Q)); 5. Screen positive for PTSD (defined as a PCL-5 score ≥32 or meeting ≥3 out of 4 DSM-5 symptom criteria \[B, C, D, E\] on the PCL-5), and/or depression (PHQ-9 score ≥8), and/or low parenting self-efficacy (PSOC score \<59); 6. Able to speak and understand English or Spanish; 7. Eligible to receive services at a Steven A. Cohen Military Family Clinic at Endeavors. Exclusion Criteria: 1. High risk for suicide (Ask Suicide-Screening Questions (ASQ)); 2. Current psychotic symptoms (DSM-5-TR Self-Rated Level 1 Cross-Cutting Symptom Measure Domain VII); 3. Disability affecting communication, such as deafness; 4. Index child with severe developmental disability; 5. Severe substance or alcohol use (The Alcohol, Smoking and Substance Involvement Screening Test - Lite (ASSIST-Lite); Cannabis Use Disorder Identification Test-Short Form (CUDIT-SF)).
Contact & Investigator
Kathrine S Sullivan, PhD
PRINCIPAL INVESTIGATOR
New York University
Frequently Asked Questions
Who can join the NCT06262178 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying PTSD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06262178 currently recruiting?
Yes, NCT06262178 is actively recruiting participants. Contact the research team at ks5313@nyu.edu for enrollment information.
Where is the NCT06262178 trial being conducted?
This trial is being conducted at El Paso, United States, Killeen, United States, San Antonio, United States.
Who is sponsoring the NCT06262178 clinical trial?
NCT06262178 is sponsored by New York University. The principal investigator is Kathrine S Sullivan, PhD at New York University. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.